Scribe Therapeutics
Biotechnology ResearchCalifornia, United States51-200 Employees
Scribe is enabling the creation of genetic medicines through its CRISPR by Design™ approach to genetic modification.
Insights
Strategic Partnerships Scribe Therapeutics has recently expanded its partnership with Sonafi and collaborated with Eli Lilly and Prevail Therapeutics, indicating a focus on developing in vivo CRISPR-based therapies. This presents a sales opportunity for companies looking to collaborate on cutting-edge genetic medicine solutions.
Specialized Technology Scribe Therapeutics utilizes advanced technologies like CasX and its CRISPR by Design™ approach. Companies offering complementary tech solutions or services can leverage this expertise to present tailored offerings, enhancing their sales pitch to Scribe and similar biotech firms.
Key Personnel Hiring Scribe Therapeutics recently appointed Dr. Aarif Khakoo and Dr. Maria Mirotsou to key positions. Sales professionals could target these new executives to introduce relevant products or services that cater to their specific roles, potentially fostering lucrative business partnerships.
Market Expansion With Scribe's focus on developing genetic medicines for neurological and neuromuscular diseases, there is a growing market for therapies in those areas. Sales representatives specializing in these therapeutic areas can explore collaboration opportunities with Scribe to tap into this expanding market segment.
Funding Potential Despite having zero external funding recorded, Scribe Therapeutics operates within the revenue range of $10M - $50M. Companies offering financial solutions or investment opportunities can approach Scribe with tailored funding propositions to support its growth and research initiatives.
Similar companies to Scribe Therapeutics
ElevateBio
570
$50M$100MMammoth Biosciences
189$10M$50MAro Biotherapeutics
50$10MBeam Therapeutics
507$100M$1BPairwise
115$10M$50MInscripta
26Metagenomi
240$10M$50M
Scribe Therapeutics Tech Stack
Scribe Therapeutics uses 8 technology products and services including Apache Spark, Amazon Redshift, git, and more. Explore Scribe Therapeutics's tech stack below.
- Apache SparkBig Data Processing
- Amazon RedshiftData Warehousing
- gitDevelopment
- Microsoft ExcelEditors
- NetSuite ERPEnterprise Resource Planning
- jQueryJavascript Libraries
- PythonProgramming Languages
- LinuxProgramming Languages
Media & News
Scribe Therapeutics's Email Address Formats
Scribe Therapeutics uses at least 1 format(s):
| Scribe Therapeutics Email Formats | Percentage |
| FLast@scribetx.com | 75% |
| First@scribetx.com | 22% |
| First.Last@scribetx.com | 2% |
| Last@scribetx.com | 1% |
Frequently Asked Questions
Where is Scribe Therapeutics's headquarters located?
Scribe Therapeutics's main headquarters is located at 1150 Marina Village Pkwy Alameda, CA 94501 US. The company has employees across 3 continents, including North AmericaEuropeAfrica. What is Scribe Therapeutics's official website and social media links?
Scribe Therapeutics's official website is scribetx.com and has social profiles on LinkedIn.How much revenue does Scribe Therapeutics generate?
As of October 2024, Scribe Therapeutics's annual revenue reached $15M. What is Scribe Therapeutics's SIC code NAICS code?
Scribe Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does Scribe Therapeutics have currently?
As of October 2024, Scribe Therapeutics has approximately 127 employees across 3 continents, including North AmericaEuropeAfrica. Key team members include Chief Business Officer: S. L.Chief Scientific Officer: A. K.Chief Financial Officer: D. P.. Explore Scribe Therapeutics's employee directory with LeadIQ.What industry does Scribe Therapeutics belong to?
Scribe Therapeutics operates in the Biotechnology Research industry. What technology does Scribe Therapeutics use?
Scribe Therapeutics's tech stack includes Apache SparkAmazon RedshiftgitMicrosoft ExcelNetSuite ERPjQueryPythonLinux. What is Scribe Therapeutics's email format?
Scribe Therapeutics's email format typically follows the pattern of . Find more Scribe Therapeutics email formats with LeadIQ. 
Company Overview
- Headquarters
- 1150 Marina Village Pkwy Alameda, CA 94501 US
- Website
- scribetx.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Employees
- 51-200
Funding & Financials
- $10M$50M
Scribe Therapeutics's revenue is in the range of $10M$50M
Funding & Financials
- $10M$50M
Scribe Therapeutics's revenue is in the range of $10M$50M
Company Leadership
S. L.Chief Business Officer
A. K.Chief Scientific Officer- D. P.Chief Financial Officer
- K. O. B.Vice President Translational Sciences
- S. S.Vice President Process Science
Employee Directory
D. S.Co-Founder- K. O. B.Vice President Translational Sciences
- V. S.Vice President, Talent
- K. H.Senior Scientist, Tech Platform, Head Of High-Throughput Assay Process And Automation
- S. M.Vp, Program Management
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
